Imexpharm Corporation (HOSE: IMP)
68,700
Open68,200
High69,100
Low67,800
Vol16,100
Market Cap.4,809.32
Remain Bid8,300
Remain Ask3,500
52Wk High69,300
52Wk Low44,100
52Wk Avg Vol19,867
Foreign Buy-
Frgn Owned(%)49.58
Dividend1,000
Dividend Yield0.01
Beta0.43
EPS4,444
P/E15.30
F P/E17.32
BVPS29,778
P/B2.28
Date | Close | Change | Volume |
---|---|---|---|
03/29/2024 | 68,700 | 700 (+1.03%) | 16,100 |
03/28/2024 | 68,000 | 0 (0.00%) | 7,600 |
03/27/2024 | 68,000 | 600 (+0.89%) | 17,800 |
03/26/2024 | 67,400 | -500 (-0.74%) | 17,200 |
03/25/2024 | 67,900 | -1,400 (-2.02%) | 28,500 |
10/05/2023 | IMP Dividend payment in cash with 10.00% for 2022 (Record date) |
10/05/2023 | IMP Dividend payment in cash with 10.00% for 2022 |
10/05/2023 | IMP Dividend payment by share with 5.00% for 2022 (Record date) |
05/25/2022 | IMP Dividend payment in cash with 15.00% for 2021 (Record date) |
05/25/2022 | IMP Dividend payment in cash with 15.00% for 2021 |
03/27/2024 | Audited FS 2023 |
01/30/2024 | Corporate Governance Report 2023 |
01/19/2024 | FS Quarter 4 of 2023 |
10/30/2023 | Regulations 2023 |
10/18/2023 | FS Quarter 3 of 2023 |
Name: Imexpharm Corporation
Abbreviation:IMEXPHARM
Address: No 4, Street 30/4, Ward 1, Cao Lanh Dong Thap
Telephone: (84.277) 385 1620
Fax: (84.277) 385 3106
Email:imp@imexpharm.com
Website:http://www.imexpharm.com
Exchange: HOSE
Sector: Manufacturing
Industry: Chemical - Pharmaceutical
Listing date: 12/04/2006
Chartered capital: 700,384,490,000
Listed shares: 70,038,449
Shares outstanding: 70,004,649
Status: Operating
Tax code: 1400384433
Establishment license: 907/QĐTg
Issued date: 07/25/2001
Business license: 1400384433
Issued date: 08/01/2001
Main business scope:
- Manufacturing pharmaceuticals, traditional medicines, cosmetics, foods, soda and sterilizing substances.
- Trading pharmaceuticals, chemicals, medical equipment.
- Providing warehouse system.
- Others under business license.
- 28 September 1983: Dong Thap pharmaceutical enterprises, forerunner of the company. belonging to Dong Thap Health Department was established.
- November 1992: Renamed as Dong Thap Pharmaceutical company, belonging to Dong Thap People's Committee.
- November 1999: Renamed as Central Pharmaceutical Company No.7, belonging to Vietnam Pharmaceutical Company.
- July 2001: Transformed to Inexpharm Pharmaceutical Joint Stock Company with a charter capital of VND22 billion.
- March 2005: Increased the charter capital to VND44 billion.
- 04 December 2006: The company was listed on HOSE.
- 06 March 2017: Increased the charter capital to VND376,254,390,000;
- 15 June 2017: Increased the charter capital to VND429,781,510,000.
- 21 June 2018: Increased the charter capital to VND429,781,510,000.
- 31 July 2020: Increased the charter capital to VND642,360,700,000.
- 20 October 2020: Increased the charter capital to VND667,053,700,000.
- 04/26/2024 IMP General Meeting of Shareholders for 2024
- 11/10/2023 IMP Annoucement of the change of listing - 3,333,079 shares
- 11/03/2023 IMP Decision on the change of listing - 3,333,079 shares
- 10/05/2023 IMP Dividend payment by share with 5.00% for 2022 (Record date)
- 10/05/2023 IMP Dividend payment in cash with 10.00% for 2022 (Record date)
Items | Unit |
---|---|
Price | VND |
Volume | Shares |
Foreigner's, Yield | % |
Mkt Cap | bVND |
Financial indicators | mVND |
EPS, BVPS, Dividend | VND |
P/E, F P/E, P/B | Times |
ROS, ROA, ROE | % |
2. F PE is taken from the estimates of earnings announced by listed companies.
3. 3-month/6-month/12-month price charts are compiled from revised data.